SCLX CIK: 1820190

Scilex Holding Co

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.7
FY22:
−21.3
FY23:
−20.7
FY24:
19.3
FY25:
3.82
millions USD
FY21:
0
FY22:
−2.07
FY23:
−0.33
FY24:
−2.68
FY25:
4.08
Change from FY21 to FY25
millions USD
FY21:
28.2
FY22:
21.2
FY23:
23.6
FY24:
−18.1
FY25:
−5.46
millions USD
FY21:
−0.50
FY22:
−2.15
FY23:
2.55
FY24:
−1.46
FY25:
1.68
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.7
FY22:
−21.3
FY23:
−20.7
FY24:
19.3
FY25:
3.68

All amounts in millions USD Data source:SEC EDGAR